\-\ Texto\\:\\ \ \(0\)\
\-\ pain\\ over\\ site\\ of\\ acromioclavicular\\ region\\.\ \(0\)\
\-\ conservative\\ treatment\ \(40\)\
\-\ there\\ is\\ an\\ erosion\\ of\\ the\\ lateral\\ head\\ of\\ the\\ clavicle\\.\\ no\\ other\\ osseous\\ findings\\.\ \(0\)\
\-\ osteolysis\\ of\\ distal\\ clavicle\\.\ \(0\)\
\-\ differential\\ of\\ acquired\\ acroosteolysis\ \(0\)\
\-\ trauma\\/injury\ \(0\)\
\-\ systemic\\ diseases\\:\ \(0\)\
\-\ diabetes\ \(101\)\
\-\ dermatomyositis\ \(6\)\
\-\ psoriasis\ \(16\)\
\-\ ehlers\\-danlos\\ syndrome\ \(0\)\
\-\ rheumatoid\\ arthritis\ \(67\)\
\-\ reiters\ \(2\)\
\-\ scleroderma\ \(13\)\
\-\ sarcoidosis\ \(108\)\
\-\ hyperparathyroidism\ \(35\)\
\-\ raynaud\\ disease\ \(0\)\
\-\ drug\\ therapy\\:\ \(1\)\
\-\ dilantin\ \(3\)\
\-\ pvc\\ \\(polyvinylchloride\\)\\ exposure\ \(0\)\
\-\ ergot\\ therapy\ \(0\)\
\-\ patient\\ is\\ status\\ post\\ acromioclavicular\\ trauma\\ during\\ a\\ flag\\ football\\ game\\ at\\ college\\ reunion\\.\\ although\\ the\\ initial\\ soreness\\ went\\ away\\,\\ the\\ patient\\ states\\ over\\ the\\ last\\ few\\ weeks\\ there\\ has\\ been\\ a\\ constant\\ increased\\ sensation\\/pain\\ at\\ that\\ site\\.\ \(0\)\
\-\ see\\ factoid\\.\ \(59\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ acromioclavicular\\:\\ 0\\.10387704459710309\ \(0\)\
\-\ clavicle\\:\\ 0\\.09678378064000209\ \(0\)\
\-\ trauma\\/injury\\:\\ 0\\.0823880226538925\ \(0\)\
\-\ polyvinylchloride\\:\\ 0\\.0823880226538925\ \(0\)\
\-\ ergot\\:\\ 0\\.0823880226538925\ \(0\)\
\-\ reunion\\:\\ 0\\.0823880226538925\ \(0\)\
\-\ sensation\\/pain\\:\\ 0\\.0823880226538925\ \(0\)\
\-\ acroosteolysis\\:\\ 0\\.07591001162062198\ \(0\)\
\-\ pvc\\:\\ 0\\.07591001162062198\ \(0\)\
\-\ raynaud\\:\\ 0\\.07212061808690082\ \(0\)\
\-\ site\\:\\ 0\\.06750489227831219\ \(0\)\
\-\ reiters\\:\\ 0\\.06734654683675137\ \(0\)\
\-\ soreness\\:\\ 0\\.06734654683675137\ \(0\)\
\-\ dilantin\\:\\ 0\\.06295398955408095\ \(0\)\
\-\ flag\\:\\ 0\\.06295398955408095\ \(0\)\
\-\ dermatomyositis\\:\\ 0\\.05916459602035978\ \(0\)\
\-\ osteolysis\\:\\ 0\\.05772393546122653\ \(0\)\
\-\ ehlers\\-danlos\\:\\ 0\\.05772393546122653\ \(0\)\
\-\ college\\:\\ 0\\.05772393546122653\ \(0\)\
\-\ psoriasis\\:\\ 0\\.05707914226975969\ \(0\)\
\-\ game\\:\\ 0\\.05393454192750537\ \(0\)\
\-\ scleroderma\\:\\ 0\\.050601131236489176\ \(0\)\
\-\ constant\\:\\ 0\\.048641126274039936\ \(0\)\
\-\ football\\:\\ 0\\.04681173770276802\ \(0\)\
\-\ away\\:\\ 0\\.04640533478744336\ \(0\)\
\-\ acquired\\:\\ 0\\.04281693382588073\ \(0\)\
\-\ therapy\\:\\ 0\\.04270356628487127\ \(0\)\
\-\ went\\:\\ 0\\.04254989296191759\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.04191387928673053\ \(0\)\
\-\ exposure\\:\\ 0\\.04155206141588296\ \(0\)\
\-\ drug\\:\\ 0\\.04097851986096433\ \(0\)\
\-\ over\\:\\ 0\\.04066621663813014\ \(0\)\
\-\ erosion\\:\\ 0\\.040333726669497506\ \(0\)\
\-\ diseases\\:\\ 0\\.04023045717242662\ \(0\)\
\-\ diabetes\\:\\ 0\\.03953785930183108\ \(0\)\
\-\ systemic\\:\\ 0\\.03820682808648745\ \(0\)\
\-\ rheumatoid\\:\\ 0\\.037723317110794095\ \(0\)\
\-\ states\\:\\ 0\\.03756755026513791\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.036071881928647076\ \(0\)\
\-\ few\\:\\ 0\\.03594116938682708\ \(0\)\
\-\ arthritis\\:\\ 0\\.0341189948602148\ \(0\)\
\-\ last\\:\\ 0\\.0341189948602148\ \(0\)\
\-\ osseous\\:\\ 0\\.03390778147781068\ \(0\)\
\-\ conservative\\:\\ 0\\.03189571067377774\ \(0\)\
\-\ status\\:\\ 0\\.02850773197366031\ \(0\)\
\-\ factoid\\:\\ 0\\.027994724239384452\ \(0\)\
\-\ although\\:\\ 0\\.02697130168763181\ \(0\)\
\-\ initial\\:\\ 0\\.026463384516629045\ \(0\)\
\-\ differential\\:\\ 0\\.025354764760307753\ \(0\)\
\-\ post\\:\\ 0\\.02514799096329246\ \(0\)\
\-\ during\\:\\ 0\\.024439338784334654\ \(0\)\
\-\ see\\:\\ 0\\.02383380571241858\ \(0\)\
\-\ there\\:\\ 0\\.02377038423299044\ \(0\)\
\-\ syndrome\\:\\ 0\\.02284024838069758\ \(0\)\
\-\ weeks\\:\\ 0\\.022666147260758395\ \(0\)\
\-\ head\\:\\ 0\\.02265047953807379\ \(0\)\
\-\ region\\:\\ 0\\.022557020815320676\ \(0\)\
\-\ trauma\\:\\ 0\\.021841203567831112\ \(0\)\
\-\ been\\:\\ 0\\.021727055041719543\ \(0\)\
\-\ distal\\:\\ 0\\.02171288400884137\ \(0\)\
\-\ at\\:\\ 0\\.02164043276320809\ \(0\)\
\-\ \\:\\:\\ 0\\.021126632074591867\ \(0\)\
\-\ increased\\:\\ 0\\.019537240951398648\ \(0\)\
\-\ other\\:\\ 0\\.0184078369037612\ \(0\)\
\-\ lateral\\:\\ 0\\.017258579865650003\ \(0\)\
\-\ findings\\:\\ 0\\.016998476035420183\ \(0\)\
\-\ treatment\\:\\ 0\\.01616464448225128\ \(0\)\
\-\ patient\\:\\ 0\\.016011064129278278\ \(0\)\
\-\ has\\:\\ 0\\.01499719598592783\ \(0\)\
\-\ that\\:\\ 0\\.0137942124164376\ \(0\)\
\-\ disease\\:\\ 0\\.013053621880520599\ \(0\)\
\-\ an\\:\\ 0\\.01104359686247411\ \(0\)\
\-\ is\\:\\ 0\\.010510108007191132\ \(0\)\
\-\ pain\\:\\ 0\\.009753347360100324\ \(0\)\
\-\ no\\:\\ 0\\.008041534118727121\ \(0\)\
\-\ a\\:\\ 0\\.007413080407824322\ \(0\)\
\-\ \\(\\:\\ 0\\.006751044170503369\ \(0\)\
\-\ \\)\\:\\ 0\\.006668576561806589\ \(0\)\
\-\ the\\:\\ 0\\.00646024694876756\ \(0\)\
\-\ of\\:\\ 0\\.005444102841027497\ \(0\)\
\-\ \\,\\:\\ 0\\.002530000612311097\ \(0\)\
\-\ \\.\\:\\ 0\\.0023223995577703166\ \(0\)\
